Dario publishes new peer-reviewed study that deepens the body of evidence that managing cardiometabolic conditions in one integrated platform improves clinical outcomes

Quasi-randomized study demonstrates the value of dario's integrated approach to provide one solution for members to manage diabetes, pre-diabetes, blood pressure, weight and taking a glp-1 new york , april 25, 2024 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today new research published in the leading peer-reviewed journal for digital health and medicine, journal of internet medicine (jmir) demonstrating a clinically significant reduction in blood glucose levels for members using dario to manage weight alongside diabetes. more than 80% of people living with type 2 diabetes are overweight and the two conditions are closely linked to the same underlying unhealthy behaviors.
DRIO Ratings Summary
DRIO Quant Ranking